Dr. Batalini is a medical oncologist focused on the treatment of breast and gynecological cancers. He is an Assistant Professor of Oncology in the Mayo Clinic College of Medicine. He is a member of the American Society of Clinical Oncology (ASCO) and American Association for Cancer Research (AACR). Dr. Batalini is a reviewer of the most prominent oncology journals and leads research in the fields of genetics and genomics, with expertise on precision oncology, liquid biopsies, DNA damage and repair, and the development of new treatments for cancer patients. His clinical and research focus includes:
- Precision medicine: identifying genetic alterations unique to each patient to guide treatment choices or clinical trial participation.
- Liquid biopsies: studies the incorporation of new technologies to individualize care and bring research findings to patient care.
- DNA damage and repair: development of genomic biomarkers of homologous recombination repair.
- Hereditary cancers: expertise on the treatment of patients with strong family history of cancer or carriers of hereditary mutations of cancer risk genes, including BRCA1, BRCA2, and others.
Mayo Clinic locations
Fellow - Hematology and OncologyBeth Israel Deaconess Medical Center, Harvard Medical School
Residency - Internal MedicineBoston University Medical Center, Boston University School of Medicine
Post Doctoral Fellowship - Genomics & Computational BiologyBroad Institute of Harvard and MIT
Activities and honors
Internal MedicineAmerican Board of Internal Medicine
Awards and honors
Conquer Cancer Merit AwardAmerican Society of Clinical Oncology
Extraordinary Effort AwardBeth Deaconess Medical Center, Harvard Medical School
Ariel Weisman Teaching AwardBoston University School of Medicine
Embassy Excellence Award for Services to the Brazilian CommunityBrazilian Consulate General
First Runner-Up Poster Presentation at resident research categoryAmerican College of Physicians
Semi-finalist at Mathematics OlympicsMathematics Brazilian Society
- 2018 - present
MemberAmerican Association for Cancer Research
- 2017 - present
MemberAmerican Society of Clinical Oncology